Irbejub H Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Tabulated summary of undesirable effects are provided as follows. (See Table 1.)

Click on icon to see table/diagram/image

Additional information on individual components: in addition to the adverse reactions listed previously for the combination product, other adverse reactions previously reported with one of the individual components may be potential adverse reactions with Irbesartan and Hydrochlorothiazide tablet. Tables 2 and 3 as follows detail the adverse reactions reported with the individual components of Irbesartan and Hydrochlorothiazide tablet. (See Tables 2 and 3.)

Click on icon to see table/diagram/image

Click on icon to see table/diagram/image

The dose-dependent adverse events of hydrochlorothiazide (particularly electrolyte disturbances) may increase when titrating the hydrochlorothiazide.
Description of selected adverse reactions: Non-melanoma skin cancer: Based on available data from epidemiological studies, cumulative dose-dependent association between HCTZ and NMSC has been observed.

View ADR Monitoring Form

Irbejub H Adverse Reactions

irbesartan + hydrochlorothiazide

Manufacturer:

Pharmaniaga Marketing

Distributor:

Pharmaniaga Logistics